Global Vortioxetine Hydrobromide Tablets 麻豆原创 Research Report 2025

Publication ID:

PB502253558

Publication Date:

February 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Vortioxetine Hydrobromide Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vortioxetine Hydrobromide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vortioxetine Hydrobromide Tablets.
The Vortioxetine Hydrobromide Tablets market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vortioxetine Hydrobromide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vortioxetine Hydrobromide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
H.Lundbeck A/S
Kanghong Pharmaceutical
Takeda Pharmaceuticals USA
Takeda Pharmaceutical
Zydus Pharms
CSPC Ouyi Pharmaceutical
Brilliant Pharmaceutical
Chiatai Tianqing
Sino Biopharmaceutical
Segment by Type
5mg
10mg
20mg
Segment by Application
Antidepressants
Anxiolytics
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vortioxetine Hydrobromide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vortioxetine Hydrobromide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vortioxetine Hydrobromide Tablets 麻豆原创 Overview
1.1 Product Definition
1.2 Vortioxetine Hydrobromide Tablets by Type
1.2.1 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 5mg
1.2.3 10mg
1.2.4 20mg
1.3 Vortioxetine Hydrobromide Tablets by Application
1.3.1 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Antidepressants
1.3.3 Anxiolytics
1.4 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vortioxetine Hydrobromide Tablets Revenue 2020-2031
1.4.2 Global Vortioxetine Hydrobromide Tablets Sales 2020-2031
1.4.3 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vortioxetine Hydrobromide Tablets 麻豆原创 Competition by Manufacturers
2.1 Global Vortioxetine Hydrobromide Tablets Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Vortioxetine Hydrobromide Tablets Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Vortioxetine Hydrobromide Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vortioxetine Hydrobromide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Product Type & Application
2.7 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Date of Enter into This Industry
2.8 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Competitive Situation and Trends
2.8.1 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Vortioxetine Hydrobromide Tablets Players 麻豆原创 Share by Revenue
2.8.3 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Scenario by Region
3.1 Global Vortioxetine Hydrobromide Tablets 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2020-2031
3.2.1 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2020-2025
3.2.2 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2026-2031
3.3 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2020-2031
3.3.1 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2020-2025
3.3.2 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2026-2031
3.4 North America Vortioxetine Hydrobromide Tablets 麻豆原创 Facts & Figures by Country
3.4.1 North America Vortioxetine Hydrobromide Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.4.3 North America Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vortioxetine Hydrobromide Tablets 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vortioxetine Hydrobromide Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.5.3 Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vortioxetine Hydrobromide Tablets 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Vortioxetine Hydrobromide Tablets 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vortioxetine Hydrobromide Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Vortioxetine Hydrobromide Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vortioxetine Hydrobromide Tablets 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vortioxetine Hydrobromide Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.7.3 Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vortioxetine Hydrobromide Tablets 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vortioxetine Hydrobromide Tablets 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vortioxetine Hydrobromide Tablets Sales by Type (2020-2031)
4.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Type (2020-2025)
4.1.2 Global Vortioxetine Hydrobromide Tablets Sales by Type (2026-2031)
4.1.3 Global Vortioxetine Hydrobromide Tablets Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2020-2031)
4.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2020-2025)
4.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2026-2031)
4.2.3 Global Vortioxetine Hydrobromide Tablets Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Vortioxetine Hydrobromide Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vortioxetine Hydrobromide Tablets Sales by Application (2020-2031)
5.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Application (2020-2025)
5.1.2 Global Vortioxetine Hydrobromide Tablets Sales by Application (2026-2031)
5.1.3 Global Vortioxetine Hydrobromide Tablets Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2020-2031)
5.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2020-2025)
5.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2026-2031)
5.2.3 Global Vortioxetine Hydrobromide Tablets Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Vortioxetine Hydrobromide Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 H.Lundbeck A/S
6.1.1 H.Lundbeck A/S Company Information
6.1.2 H.Lundbeck A/S Description and Business Overview
6.1.3 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product Portfolio
6.1.5 H.Lundbeck A/S Recent Developments/Updates
6.2 Kanghong Pharmaceutical
6.2.1 Kanghong Pharmaceutical Company Information
6.2.2 Kanghong Pharmaceutical Description and Business Overview
6.2.3 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.2.5 Kanghong Pharmaceutical Recent Developments/Updates
6.3 Takeda Pharmaceuticals USA
6.3.1 Takeda Pharmaceuticals USA Company Information
6.3.2 Takeda Pharmaceuticals USA Description and Business Overview
6.3.3 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product Portfolio
6.3.5 Takeda Pharmaceuticals USA Recent Developments/Updates
6.4 Takeda Pharmaceutical
6.4.1 Takeda Pharmaceutical Company Information
6.4.2 Takeda Pharmaceutical Description and Business Overview
6.4.3 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.4.5 Takeda Pharmaceutical Recent Developments/Updates
6.5 Zydus Pharms
6.5.1 Zydus Pharms Company Information
6.5.2 Zydus Pharms Description and Business Overview
6.5.3 Zydus Pharms Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zydus Pharms Vortioxetine Hydrobromide Tablets Product Portfolio
6.5.5 Zydus Pharms Recent Developments/Updates
6.6 CSPC Ouyi Pharmaceutical
6.6.1 CSPC Ouyi Pharmaceutical Company Information
6.6.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.6.3 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.6.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.7 Brilliant Pharmaceutical
6.7.1 Brilliant Pharmaceutical Company Information
6.7.2 Brilliant Pharmaceutical Description and Business Overview
6.7.3 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.7.5 Brilliant Pharmaceutical Recent Developments/Updates
6.8 Chiatai Tianqing
6.8.1 Chiatai Tianqing Company Information
6.8.2 Chiatai Tianqing Description and Business Overview
6.8.3 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product Portfolio
6.8.5 Chiatai Tianqing Recent Developments/Updates
6.9 Sino Biopharmaceutical
6.9.1 Sino Biopharmaceutical Company Information
6.9.2 Sino Biopharmaceutical Description and Business Overview
6.9.3 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.9.5 Sino Biopharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vortioxetine Hydrobromide Tablets Industry Chain Analysis
7.2 Vortioxetine Hydrobromide Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vortioxetine Hydrobromide Tablets Production Mode & Process Analysis
7.4 Vortioxetine Hydrobromide Tablets Sales and 麻豆原创ing
7.4.1 Vortioxetine Hydrobromide Tablets Sales Channels
7.4.2 Vortioxetine Hydrobromide Tablets Distributors
7.5 Vortioxetine Hydrobromide Tablets Customer Analysis
8 Vortioxetine Hydrobromide Tablets 麻豆原创 Dynamics
8.1 Vortioxetine Hydrobromide Tablets Industry Trends
8.2 Vortioxetine Hydrobromide Tablets 麻豆原创 Drivers
8.3 Vortioxetine Hydrobromide Tablets 麻豆原创 Challenges
8.4 Vortioxetine Hydrobromide Tablets 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

H.Lundbeck A/S
Kanghong Pharmaceutical
Takeda Pharmaceuticals USA
Takeda Pharmaceutical
Zydus Pharms
CSPC Ouyi Pharmaceutical
Brilliant Pharmaceutical
Chiatai Tianqing
Sino Biopharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.